| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.16B | +2.7% |
| Cost of Revenue | $6.41B | -0.6% |
| Gross Profit | $1.75B | +17.1% |
| R&D Expense | $63.0M | +21.2% |
| Operating Income | $957.0M | +25.6% |
| Pre-tax Income | $839.0M | +25.6% |
| Income Tax | $188.0M | +13.3% |
| Net Income | $643.0M | +30.7% |
| EPS (Basic) | $9.74 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $401.0M | +69.9% |
| Accounts Receivable | $1.28B | -9.4% |
| Inventory | $1.45B | -9.2% |
| Current Assets | $3.40B | +2.7% |
| Total Assets | $7.64B | +1.1% |
| Current Liabilities | $1.77B | -5.8% |
| Long-term Debt | $1.74B | -10.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.06B | +595.4% |
| Capital Expenditures | $316.0M | +5.3% |
| Investing Cash Flow | -$329.0M | -2.8% |
| Financing Cash Flow | -$569.0M | -652.4% |
| Free Cash Flow | $741.0M | +600.7% |
| +31.1% |
| EPS (Diluted) | $9.60 | +30.8% |
| Total Liabilities |
| $3.99B |
| -7.1% |
| Stockholders' Equity | $3.54B | +12.4% |